Fish oil reduces sudden cardiac death in post myocardial infarction patients.
What does PMI stand for?
PMI stands for Post Myocardial Infarction
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of PMI
We have 298 other meanings of PMI in our Acronym Attic
- Point of Maximal Impulse
- Point of Maximum Impulse
- Policy Management Infrastructure
- Politico-Military Interactions
- Positive Material Identification
- Positive Material Inspection
- Post Merge Integration
- Post Mortem Interval (forensics; time from when death occurs until the body is discovered)
- Post Musical Instruments (Netherlands)
- Post-Merger Integration
- Power Margin Indicator
- Power Medical Interventions (Langhorne, PA)
- Pre-Market Indicator
- Precept Ministries International (Chattanooga, TN)
- Precoding Matrix Indicator (telecommunications)
- Preliminary Marksmanship Instruction
- Present-Minded Individualism
- Preservation Management Institute (various locations)
- Presidential Management Intern
Samples in periodicals archive:
Anti-heart antibodies in the post cardiotomy and post myocardial infarction syndromes.
However, "any degree of anemia has an adverse effect on long-term mortality post myocardial infarction," with each lower quintile of hemoglobin at the time of an MI admission associated with an increased risk of death, noted Dr.
The pre-clinical data demonstrate that BL-1040 is effective in improving cardiac function and preventing the deterioration of myocardium post myocardial infarction (MI) in pigs.
A study in Switzerland of 88 men and 12 women was conducted 11 months post myocardial infarction (Bloch, Maeder, & Haissly, 1975).
The pre-clinical data demonstrate that BL-1040 is effective in improving cardiac function and preventing the deterioration of myocardium post myocardial infarction (MI), in pigs.
Its lead product, BL-1020, for the treatment of schizophrenia, successfully completed Phase 1 clinical trials; and BL-1040, for the treatment of damaged heart tissue post myocardial infarction, is expected to enter the clinic in early 2007.
Previous myocardial infarction and coronary artery disease (CAD), at least 40 days post myocardial infarction and three months post coronary artery revascularization surgery with an ejection fraction equal to or less than 35% after maximal medical therapy; or 7.